315 related articles for article (PubMed ID: 36232431)
1. Molecular Docking and In-Silico Analysis of Natural Biomolecules against Dengue, Ebola, Zika, SARS-CoV-2 Variants of Concern and Monkeypox Virus.
Dassanayake MK; Khoo TJ; Chong CH; Di Martino P
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232431
[TBL] [Abstract][Full Text] [Related]
2. Transchromosomic bovines-derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS-CoV-2, MERS-CoV, Ebola, Zika, HIV-1, and influenza A virus.
Saied AA; Nascimento MSL; do Nascimento Rangel AH; Skowron K; Grudlewska-Buda K; Dhama K; Shah J; Abdeen A; El-Mayet FS; Ahmed H; Metwally AA
J Med Virol; 2022 Oct; 94(10):4599-4610. PubMed ID: 35655326
[TBL] [Abstract][Full Text] [Related]
3. Defective Interfering Particles with Broad-Acting Antiviral Activity for Dengue, Zika, Yellow Fever, Respiratory Syncytial and SARS-CoV-2 Virus Infection.
Lin MH; Li D; Tang B; Li L; Suhrbier A; Harrich D
Microbiol Spectr; 2022 Dec; 10(6):e0394922. PubMed ID: 36445148
[TBL] [Abstract][Full Text] [Related]
4.
Pandey AK; Verma S
Drug Dev Ind Pharm; 2022 Oct; 48(10):539-551. PubMed ID: 36250723
[TBL] [Abstract][Full Text] [Related]
5. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.
Abdizadeh R; Hadizadeh F; Abdizadeh T
Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728
[TBL] [Abstract][Full Text] [Related]
6. Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations.
Dhameliya TM; Nagar PR; Gajjar ND
Mol Divers; 2022 Oct; 26(5):2775-2792. PubMed ID: 35132518
[TBL] [Abstract][Full Text] [Related]
7. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
8. In silico study of azithromycin, chloroquine and hydroxychloroquine and their potential mechanisms of action against SARS-CoV-2 infection.
Braz HLB; Silveira JAM; Marinho AD; de Moraes MEA; Moraes Filho MO; Monteiro HSA; Jorge RJB
Int J Antimicrob Agents; 2020 Sep; 56(3):106119. PubMed ID: 32738306
[TBL] [Abstract][Full Text] [Related]
9. Computational profiling of natural compounds as promising inhibitors against the spike proteins of SARS-CoV-2 wild-type and the variants of concern, viral cell-entry process, and cytokine storm in COVID-19.
Kar P; Saleh-E-In MM; Jaishee N; Anandraj A; Kormuth E; Vellingiri B; Angione C; Rahman PKSM; Pillay S; Sen A; Naidoo D; Roy A; Choi YE
J Cell Biochem; 2022 May; 123(5):964-986. PubMed ID: 35342986
[TBL] [Abstract][Full Text] [Related]
10. Broad-Spectrum Antiviral Strategies and Nucleoside Analogues.
Geraghty RJ; Aliota MT; Bonnac LF
Viruses; 2021 Apr; 13(4):. PubMed ID: 33924302
[TBL] [Abstract][Full Text] [Related]
11. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies.
Azeem M; Mustafa G; Mahrosh HS
Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514
[TBL] [Abstract][Full Text] [Related]
12. Ebselen suitably interacts with the potential SARS-CoV-2 targets: an
Sarkar C; Abdalla M; Mondal M; Khalipha ABR; Ali N
J Biomol Struct Dyn; 2022; 40(22):12286-12301. PubMed ID: 34459720
[TBL] [Abstract][Full Text] [Related]
13. In Silico Approach for the Evaluation of the Potential Antiviral Activity of Extra Virgin Olive Oil (EVOO) Bioactive Constituents Oleuropein and Oleocanthal on Spike Therapeutic Drug Target of SARS-CoV-2.
Geromichalou EG; Geromichalos GD
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364398
[TBL] [Abstract][Full Text] [Related]
14. In Silico Screening of Bioactive Compounds of Representative Seaweeds to Inhibit SARS-CoV-2 ACE2-Bound Omicron B.1.1.529 Spike Protein Trimer.
Bharathi M; Sivamaruthi BS; Kesika P; Thangaleela S; Chaiyasut C
Mar Drugs; 2022 Feb; 20(2):. PubMed ID: 35200677
[TBL] [Abstract][Full Text] [Related]
15. Unique Mode of Antiviral Action of a Marine Alkaloid against Ebola Virus and SARS-CoV-2.
Izumida M; Kotani O; Hayashi H; Smith C; Fukuda T; Suga K; Iwao M; Ishibashi F; Sato H; Kubo Y
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458549
[TBL] [Abstract][Full Text] [Related]
16. Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation.
Kar P; Kumar V; Vellingiri B; Sen A; Jaishee N; Anandraj A; Malhotra H; Bhattacharyya S; Mukhopadhyay S; Kinoshita M; Govindasamy V; Roy A; Naidoo D; Subramaniam MD
J Biomol Struct Dyn; 2022 Jul; 40(10):4532-4542. PubMed ID: 33305988
[TBL] [Abstract][Full Text] [Related]
17. Computational drug re-purposing targeting the spike glycoprotein of SARS-CoV-2 as an effective strategy to neutralize COVID-19.
Toor HG; Banerjee DI; Lipsa Rath S; Darji SA
Eur J Pharmacol; 2021 Jan; 890():173720. PubMed ID: 33160938
[TBL] [Abstract][Full Text] [Related]
18. Pharmacoinformatics-based identification of potential bioactive compounds against Ebola virus protein VP24.
Kwofie SK; Broni E; Teye J; Quansah E; Issah I; Wilson MD; Miller WA; Tiburu EK; Bonney JHK
Comput Biol Med; 2019 Oct; 113():103414. PubMed ID: 31536833
[TBL] [Abstract][Full Text] [Related]
19. Phytoconstituents from Moringa oleifera fruits target ACE2 and open spike glycoprotein to combat SARS-CoV-2: An integrative phytochemical and computational approach.
Siddiqui S; Ahmad R; Alaidarous M; Zia Q; Ahmad Mir S; Alshehri B; Srivastava A; Trivedi A
J Food Biochem; 2022 May; 46(5):e14062. PubMed ID: 35043973
[TBL] [Abstract][Full Text] [Related]
20. Andrographolide and Its 14-Aryloxy Analogues Inhibit Zika and Dengue Virus Infection.
Li F; Khanom W; Sun X; Paemanee A; Roytrakul S; Wang D; Smith DR; Zhou GC
Molecules; 2020 Oct; 25(21):. PubMed ID: 33143016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]